Company / FCF Margin
Eton Pharmaceuticals, Inc. FCF Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
21.5%
FY2025
5-year range
-57425.6% / 22.5%
FY2021-FY2025
Trend
-4.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 7 years, ranging from -57425.6% in FY2022 to 22.5% in FY2024.
Based on SEC 10-K filings.
21.5% in FY2025 with a 5-year CAGR of +895.5%.
Improved from -21.7% to 21.5% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +57447.2pp
- 5-Year Change
- +895.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin decreased 4.3% year-over-year.
- Peak fcf margin was recorded in FY2024.
- Lowest fcf margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 21.5% | -4.3% |
| FY2024 | 22.5% | +203.9% |
| FY2023 | -21.7% | +100.0% |
| FY2022 | -57425.6% | -2780.0% |
| FY2021 | -1993.9% | -128.2% |
| FY2020 | -873.9% | +9.9% |
| FY2019 | -969.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026